Posted inClinical Updates Oncology
Dynamic Prognostic Stratification of Resectable Pancreatic Cancer Using the Metro-Pancreas Framework Post-Neoadjuvant Chemotherapy
The Metro-Pancreas classification, integrating tumor size and CA 19-9 levels, effectively stratifies survival in resectable pancreatic cancer post-neoadjuvant chemotherapy, with restaging refining prognostic accuracy and guiding surgical decision-making.
